Publicaciones

1. Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990- 1999). Neffen H, Baena-Cagnani C, Passalacqua G, Canonica GW, Rocco D. Respir Med. 2006;100(8):1431-5.

2. Not well controlled asthma is associated with increased use of unschedule healthcare: Analysis in 26 countries. Lai CK, Neffen H, Vervloet D, Williams AE, Lloyd AC. Prim Care Respir J. May 2006.04.134.

3. Recomendaciones para el diagnóstico y tratamiento del asma de difícil control (ADC). D. Colodenco, H. Neffen, C. Baena Cagnani, R. Rojas, C. D. Crisci. Archivos Alergia e Inmunología Clínica Vol 37, Suplemento 1. 2006

4. Consenso Latinoamericano sobre el asma de difícil control. Neffen Hugo, Tálamo Carrillo Carlos, Barillas Rodríguez Juan Manuel, et al. Drugs of Today 2006, Vol. 42, Supl. III/MX. 2006

5. Asthma Prevalence and Risk Factors in Latin America. Neffen, H. Current Allergy & Clinical Immunology, Vol 20, Nº.1, p. 8-10. March 2007.

6. Reliability and factor analysis of the Spanish version of the Asthma Control Test. Gustavo J. Rodrigo; José Pedro Arcos, Luis J. Nannini, Hugo Neffen; Marisa González Broin, Mariela Contrera and Luis Piñeyro. Annals of Allergy, Asthma and Immunology. Volume 100, January 2008.

7.  Consenso Latinoamericano sobre el asma de difícil control. Actualización 2008. Neffen, Hugo; Tálamo Carrillo, Carlos; Colodenco, Daniel, et al. Drugs of Today, 2008, Vol. 44, Supl. 3. 2008.

8. Impacto del tratamiento preventivo con Agonistas 2 Adrenérgicos de Acción Larga y Glucocorticoides Inhalados en la morbimortalidad de 1.543 episodios de exacerbación grave de asma. V Plaza, J Bellido-Casado, GJ Rodrigo, C Torres, G Rodríguez-Trigo, R Sepúlveda, H. Neffen y M Perpiñá. Archivos de Bronconeumología. (SEPAR-ALAT), 2009; 45:545-9.

9.  Relationship between the characteristics of hospitalized acute asthma patients and the severity of their asthma. A case-control study. Gustavo J. Rodrigo, Vicente Plaza, Hugo E. Neffen, Gur Levy, Miguel Perpiñá Tordera. Allergologia et Immunopathologia, 2009; 37(5):225-229.

10. The impact of preventive treatment with long-acting b2 adrenergics agonist and inhaled glucocorticoids in the morbility and mortality of 1.543 events of severe exacerbations of asthma. Bellido-Casado J, Plaza V, Rodrigo G, Torres C, Rodriguez-Trigo G, Sepulveda R, Neffen H, Perpiña M. ERS Congress. Vienna, September 13, 2009

11. Characteristics of patients hospitalized for acute severe asthma over a ten year period (1994-2004) in Spain and Latin-america: the eagle study. Gustavo J. Rodrigo, Jesús Bellido-Casado, Hugo Neffen, María Teresa Bazús, Gur Levy, Joseph Armengol. Brazilian Journal of Pneumology, 2009; 35(7):635-644.

12.  Formoterol for acute asthma in the Emergency Department: a systematic review with meta-analysis. Gustavo J. Rodrigo, Hugo E. Neffen, Federico Daniel Colodenco, José A. Castro-Rodriguez. Ann Allergy Asthma Immunol. 2010;104:247–252

13. Nasal allergies in the Latin American population: Results from the Allergies in Latin America survey - Hugo Neffen, M.D. Joao F. Mello, Jr., M.D., Dirceu Sole, M.D., Charles K. Naspitz, M.D., Alberto Eduardo Dodero, M.D., Héctor León Garza, M.D., Edgard Novelo Guerra, D., Carlos Baez-Loyola, M.D., John M. Boyle, Ph.D., and Mark A. Wingertzahn, Ph.D. - May–June 2010, Vol. 31, No. 3 (Suppl 1).

14. How can we inprove the management of allergic rhinitis in Latin America? Neffen, H - Allergy Asthma Proc. 2010 Jun 16.

15. Ciclesonide, a hypotonic intranasal corticosteroid - Hugo Neffen, M.D., and Mark A. Wingertzahn, Ph.D. - May–June 2010, Vol. 31, No. 3 (Suppl 1).

16. Efficacy and safety of subcutaneous omalizumab versus placebo as add on therapy to corticosteroids for children and adults with asthma: a systematic review – Rodrigo, G. Neffen H, Castro-Rodriguez, J. - CHEST / 139 / 1 / JANUARY, 2011

17. Guía ALERTA 2. América Latina y España: Recomendaciones para la prevención y el Tratamiento de la exacerbación Asmática - Gustavo J. Rodrigo, Vicente Plaza Moral, Santiago Bardagí Forns, José A. Castro-Rodríguez, Alfredo de Diego Damiá, Santos Liñán Cortés, Carlos Melero Moreno, Luis J. Nannini, Hugo Neffen y Jorge Salas et al / Arch Bronconeumol. 2010;46(Supl 7):2-20

18. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. - Rodrigo GJ, Neffen, H, Clin Exp Allergy. 2010 ;41(2):160-70.

19. The Burden of Unscheduled Health Care for Asthma in Latin America - H Neffen,1 SN Gonzalez,2 CC Fritscher,3 C Dovali,4 AE Williams5 - J Investig Allergol Clin Immunol 2010; Vol. 20(7): 596-601

20. Asthma programmes in diverse regions of the World: challenges, successes and lessons learnt – U. G. Lalloo, R. D. Walters, M. Adachi, T. De Guia, A. Emelyanov, C. C. Fritscher, J. Hong, C. Jimenez, G. G. King, J. Lin, A. Loaiza, G. Nadeau, H. Neffen, B. E. Sekerel, A. Yorgancioglu, H. J. Zar.Int J Tuberc Lung Dis. 2011 Dec;15(12):1574-87

21. Comparison of Indacaterol with Tiotropium or twice-daily long-acting Beta-agonists for stable copd: a systematic review - G. Rodrigo, H. Neffen - Chest published March 1, 2012, doi:10.1378/chest.11-2252

22. Knowledge and Management of Anaphylaxis in Primary Care Settings in Argentina. L. R. F. Ardusso, M. Carignani, L. Sanchez, J. L. Molinas, M. Ardusso, M. Gonzalez Broin, H. Neffen. JACI 2012;29(2): AB178 (#673).

23. Asma de difícil control en niños y adolescentes: estrategias diagnóstico-terapéuticas: H. Neffen, S. Vidaurreta, A. Balanzat, M. De Gennaro, V. Giubergia, J. Maspero, R. Saranz, A. Teper – Revista Medicina (Buenos Aires) 2012; 72: 403-413.

24. Consenso SEPAR-ALAT sobre terapia inhalada. Archivos de Bronconeumología. 2013. Volumen 49 - Extraordinario 1

25. Prevalencia, impacto y manejo de la rinitis alérgica en Latinoamérica. Revista de Rinología, Barcelona, España. Revista de Rinología, 2014;14(1):19-28.

26. Levels of IL-8 and IL17-A in Sputum Samples From Severe Asthma Patients. Chest 10/2013; 144 (4_MeetingAbstracts):82A.

27. Significant Increase of IL-8 Sputum Levels in Treatment Resistant Severe Asthma Compared with Difficult to Treat Severe Asthma Patients. J Genet Syndr Gene Ther 2014, http://dx.doi.org/10.4172/2157-7412.1000218

28. Guía argentina de urticaria y angioedema. Revista Medicina. (Buenos Aires) Vol. 74 Supl. I – 2014.

29. A systematic review on the efficacy and safety of a fixed-dose combination of Umeclidinium and Vilanterol for the treatment of COPD. Chest on line 2015.

30. Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents. Rodrigo GJ, Neffen H. Pediatr Allergy Immunol. 2015 May 11. doi: 10.1111/pai.12405. [Epub ahead of print]

31. MACVIA – ARIA Sentinel Network for allergic rhinitis (MASK – rhinitis): The new generation guideline implementation. J Bousquet J, HJ Schunemann, J Fonseca et al. Allergy – July 2015.

32. "Allergen Immunotherapy on the Way to Product-based Evaluation. A WAO Statement"
Authors: Claus Bachert; Mark Larche; Sergio Bonini; G Walter Canonica; Thomas Kuendig; Desiree Larenas-Linnemann; Dennis K Ledford; Hugo Neffen; Ruby Pawankar; Giovanni Passalacqua. World Allergy Organization Journal 2015, 8 :29 (16 September 2015)

33. Assessment of Acute Asthma severity in the ED: Are heart and respiratory rates relevant? The American Journal of Emergency Medicine. 33 (2015) 1583-1586. Rodrigo GJ, Neffen, H.

34. A 121/2-year journey of a patient with Samter triad syndrome and sporadic omalizumab use. Ardusso L.R.F.; Neffen, H.  Annals of Allergy, Asthma & Immunology. 115 (2015) 451-457.

39.      Prevalence And Features Of Asthma. Results Of A Population-Based Nationwide Survey In Argentina. A. J. Videla , S. Arias , J. C. Bossio , C. A. Calabrese , G. Armando , H. Neffen. Am J Respir Crit Care Med 193;2016:A2945.

40.      ASTHMA-COPD OVERLAP SYNDROME (ACOS): A CONTROVERSIAL CONCEPT. Gustavo J. Rodrigo, Hugo Neffen, Vicente Plaza. Current Opinion Allergy. In press.

41.      A SYSTEMATIC REVIEW WITH META-ANALYSIS OF FLUTICASONE FUROATE/VILANTEROL COMBINATION FOR THE TREATMENT OF STABLE COPD. Gustavo J. Rodrigo, Hugo Neffen. Journal: Pulmonary Pharmacology & Therapeutics. 42 (2017) 1 – 6.

42.      Uncontrolled Asthma in Specialized Centers in Latin America: Findings from the Asthma Control in Latin America (ASLA) Study. Hugo E. Neffen, Edith Vallejo-Perez, Marco Chahuan, et. al. AB206 - J ALLERGY CLIN IMMUNOL. FEBRUARY 2017.

43.      EFFICACY AND SAFETY OF TIOTROPIUM IN SCHOOL-AGE CHILDREN WITH MODERATE TO SEVERE SYMPTOMATIC ASTHMA: RESULTS FROM A SYSTEMATIC REVIEW WITH META-ANALYSIS. Gustavo Rodrigo, Hugo Neffen Pediatr Allergy Immunol. 2017; Sep;28(6):573-578. doi: 10.1111/pai.12759.